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Abstract
Arterial smooth muscle cells (ASMCs), the predominant cell type within the arterial wall, detect and respond to external mechanical
forces. These forces can be derived from blood flow (i.e. pressure and stretch) or from the supporting extracellular matrix (i.e. stiffness
and topography). The healthy arterial wall is elastic, allowing the artery to change shape in response to changes in blood pressure, a
property known as arterial compliance. As we age, the mechanical forces applied to ASMCs change; blood pressure and arterial wall
rigidity increase and result in a reduction in arterial compliance. These changes in mechanical environment enhance ASMC contrac-
tility and promote disease-associated changes in ASMC phenotype. For mechanical stimuli to programme ASMCs, forces must
influence the cell’s load-bearing apparatus, the cytoskeleton. Comprised of an interconnected network of actin filaments, microtubules
and intermediate filaments, each cytoskeletal component has distinct mechanical properties that enable ASMCs to respond to changes
within the mechanical environment whilst maintaining cell integrity. In this review, we discuss how mechanically driven cytoskeletal
reorganisation programmes ASMC function and phenotypic switching.
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Introduction
The cellular components of our blood vessels are subjected to
numerous mechanical forces, none more so than those of the
aorta, the largest vessel in our body. Cells have evolved to not
only withstand the stresses and strains of these forces, but also
to adapt their structure and function in response to them. Large-
elastic arteries, including the aorta, possess the ability to change
shape in response to changes in blood pressure, a property
known as arterial compliance. Maintenance of arterial compli-
ance is essential for healthy ageing, with decreased compliance
and vascular stiffening being major risk factors in the develop-
ment of cardiovascular disease (CVD). Vascular stiffening has
two main effects: (1) it will increase pulse wave velocity and
lead to damage of delicate microvascular vessels, and (2) it
places increased workload on the heart, increasing the risk of
heart failure (Glasser et al. 1997; Mitchell et al. 2010).
Arterial smoothmuscle cells (ASMCs) are the predominant
cell type within the arterial wall. ASMC contraction is initiat-
ed by chemical, electrical and mechanical factors, and acts to
reduce arterial compliance (Lincoln et al. 2001; Brozovich
et al. 2016; Ahmed and Warren 2018). Mechanical forces
regulating vascular function can be derived from both blood
flow (pressure, tensile strain and shear stress) and the
supporting extracellular matrix (ECM) (stiffness, topography
and curvature) (Fig. 1a). A summary of these forces and their
regulation of the endothelium has been reviewed recently
(Dessalles et al. 2021). A key hallmark of vascular ageing
and CVD onset is arterial stiffening (Sethi et al. 2014).
ASMCs respond to increased matrix rigidity by enhancing
actomyosin force production (Qiu et al. 2010; Sehgel et al.
2015). The pathways responsible for ECM rigidity-
dependent actomyosin activity, and whether ASMCs generate
large enough forces to contract rigid arterial walls, remain
unknown.
Mechanotransduction, the ability of cells to convert me-
chanical stimuli into biochemical signals was traditionally
the function of specialised membrane-embedded ion channels.
However, it is now clear that integrins, clustered within focal
adhesions (FA), can also transduce mechanical signals from
the ECM (Alenghat and Ingber 2002; Ohashi et al. 2017). The
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ASMC contractile phenotype is found to be dependent on the
expression of specific integrins (Zargham and Thibault 2006).
In response to intraluminal pressure or cell adhesion–
associated tension, focal adhesion kinase (FAK), a
mechanosensitive component of FAs undergoes autophos-
phorylation (Lehoux et al. 2005; Ribeiro-Silva et al. 2021).
Phosphorylated FAK activates Src and potentiates FA remod-
elling, via the phosphorylation of downstream signalling mol-
ecules paxillin (PXN) and CAS. Once activated, pPXN and
pCAS initiate actin polymerisation through a Rac/RhoA me-
diated pathway (Ribeiro-Silva et al. 2021). FAs have been
shown to be major regulators of ASMC contractility and tone.
Inhibition of the FAK-Src pathway perturbs FA dynamics and
reduces ASMC stiffness (Saphirstein et al. 2013). During age-
ing, Src expression decreases, impairing ASMC plasticity and
reducing the ability of FA complexes to absorb hemodynamic
forces (Gao et al. 2014).
Although FAs can transduce mechanical force, in order to
initiate a structural or mechanical response, these signals must
be propagated through the load-bearing architecture of the
cell, the cytoskeleton (Alenghat and Ingber 2002; Ohashi
et al. 2017). The mammalian cytoskeleton is comprised of
three core components: the compression-resistant microtubule
network, and the tension-bearing actin cytoskeleton and inter-
mediate filament networks. The mechanical properties of each
component work synergistically to prevent cell rupture under
a range of mechanical stresses and strains (Sanghvi-Shah and
Weber 2017). Of these cytoskeletal components, the role of
the actin cytoskeleton in ASMC mechanotransduction is the
most studied, due to both its role in actomyosin force genera-
tion and its direct association with FAs. Actin filaments bind
to the cytoplasmic tail of β-integrins via a talin bridge. This
interaction is transient under low strains, but as tension in-
creases talin undergoes a conformational change that enables
the actin-talin linkage to be reinforced through the binding of
vinculin (Lacolley et al. 2018). As matrix rigidity increases
during ageing, greater strain is placed onto FAs and vinculin is
recruited to stabilise the FA-cytoskeleton linkage (Lacolley
et al. 2018). Further discussion on the role of FA complexes
in regulating ASMC function, phenotype and ECM organisa-
tion can be found in recent reviews (Ohanian et al. 2015;
Lacolley et al. 2018; Ribeiro-Silva et al. 2021).
In this review, we explore how the mechanical forces im-






























Fig. 1 Mechanical forces acting on ASMCs change with age. a
Mechanical forces regulating arterial function are derived from both
blood flow (shear stress and pressure) and the supporting extracellular
matrix (stiffness, topography and curvature). Mechanical forces,
including blood pressure and matrix rigidity, regulate ASMC function.
b Under physiological conditions, the arterial wall is compliant and
stretches in response to the force of blood pressure pushing against it.
ASMCs respond to the combined signals of blood pressure (compressive
force) and wall stretch by initiating actomyosin-driven contraction. c
During ageing, increased blood pressure (hypertension) generates
additional compressive force. Additionally, the stiffness of the arterial
wall increases, which decreases compliance and reduces the ability of
the arterial wall to deform. Therefore, ASMCs experience increased
compressive force and decreased stretch. Age-related changes in
mechanical cues enhance actomyosin-driven contractility which further
decreases compliance
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cytoskeleton, thereby regulating ASMC contractility and phe-
notype. Although smoothmuscle cells are constituents of both
the arterial and venous vascular wall, compositional and func-
tional differences between these vascular beds alter their be-
haviour and response to mechanical stimuli (Wadey et al.
2018). As such, this review will solely focus on the role of
ASMCs. Additionally, there are differences between ASMCs
depending on their vessel of origin, most notably between
large-elastic and small-muscular arteries (Majesky 2007; Chi
et al. 2007; Owens et al. 2010). Whilst not the main focus of
this review, we will indicate any vessel-specific differences
that alter ASMC mechanoresponse. Finally, we will discuss
how the ASMC cytoskeleton adapts to a changing mechanical
environment, focusing particularly on changes associatedwith
ageing. These being increased blood pressure and enhanced
aortic stiffness, early biomarkers of CVD.
Aortic compliance and age-associated
changes to mechanical cues
In healthy arteries, blood pressure pushes against the arterial
wall, causing it to stretch. ASMCs respond to both the com-
pressive force of blood pressure and the stretch of the arterial
wall by initiating actomyosin-driven contraction (Ye et al.
2014) (Fig. 1b). During ageing, these mechanical cues change
dramatically. Firstly, increased blood pressure results in en-
hanced blood-derived forces. Secondly, the rigidity of the ar-
terial wall increases, as a consequence of ECM remodelling.
Over time, elastin, the elastic component of the arterial wall,
degrades and is replaced by collagen-I, providing increased
tensile strength to the arterial wall (Tsamis et al. 2013). As the
rigidity of the ECM increases, arterial compliance decreases,
meaning the arterial wall is now resisting the blood-derived
forces (Ahmed and Warren 2018). Under these altered me-
chanical cues, ASMCs experience decreased stretch but in-
creased compressive forces. In response, ASMCs generate
enhanced actomyosin-derived contractile forces and further
decrease arterial compliance (Ye et al. 2014) (Fig. 1c).
Furthermore, ageing and hypertension lead to the accumula-
tion of ASMC DNA damage (Ragnauth et al. 2010; Meloche
et al. 2014). DNA damage accumulation promotes ASMC
dedifferentiation and senescence, and has been linked to the
formation and subsequent severity of atherosclerotic lesions
(Gray et al. 2015).
ECM topology, ASMC morphology
and function
ASMCs are not terminally differentiated and possess the abil-
ity to switch between contractile and proliferative phenotypes
(Ahmed and Warren 2018). Despite much research, our
understanding of this phenotypic switching remains poor. In
the arterial wall, ASMCs exist in a quiescent/contractile phe-
notype and adopt a spindle-like morphology (Alford et al.
2011). Traditionally, ASMCs have been cultured on plastic
and glass, which are around a thousand times stiffer than the
arterial wall. However, when ASMCs are isolated and ex-
panded, they exist in a proliferative phenotype and adopt a
spread, fried egg-like morphology (Fig. 2). Whilst serum
withdrawal promotes ASMCs to adopt a quiescent phenotype,
this does not fully recapitulate the contractile phenotype
displayed in vivo. Notably, expression of myosin heavy chain
(MYH11) isoforms SM1 and SM2 remain downregulated in
cultured ASMCs (Babij et al. 1992; Han et al. 2006).
Additionally, cultured ASMCs are typically assayed as indi-
vidual cells, not as a functional, multi-layered unit. This
means that the importance of communication between
neighbouring ASMC and endothelial cells can be overlooked.
However, the transmission of signals between ASMCs via
connexin (CX) gap junctions contributes to ASMC plasticity,
with the vaso-protective function of CX40 promoting a con-
tractile phenotype and upregulation of CX43 associated with
ASMC dedifferentiation (Myasoedova et al. 2020).
Multiple soluble factors and ECM rigidity have been
shown to regulate phenotypic switching and proliferation
(Ahmed andWarren 2018; Afewerki et al. 2019). More recent
studies have used ECM topological control to define ASMC
shape and orientation (Agrawal et al. 2015). Importantly,
these studies suggest that ASMC function and potentially phe-
notype are tightly coupled to morphology. Adhesion, prolif-
eration, expression of smooth muscle myosin and myogenesis
have all been linked to ASMC morphology (Thakar et al.
2009; Alford et al. 2011; Williams et al. 2011; Chaterji et al.
2014; Zhang et al. 2016). These findings suggest that when
culturing ASMCs, ECM stiffness and topological control are
important considerations. Given the current speed of techno-
logical advancement, we are heading towards systems that
will enable a more complete understanding of ASMC pheno-
typic control.
Despite the recent advancements in our understanding of
the mechanical and organisational regulation of ASMC differ-
entiation and function, we still lack a clear understanding of
how these cues are transduced. The ASMC cytoskeleton po-
tentially plays a pivotal role in resisting and responding to
mechanical cues. The cytoskeleton is also critical in defining
cell morphology. Therefore, we will next discuss how the
cytoskeleton regulates ASMC mechanotransduction.
Actin filaments—more than just a contractile
apparatus
The most studied component of the ASMC cytoskeleton is actin
filaments. Actin accounts for around 20% of VSMC protein
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content and is also a key regulator of actomyosin-driven ASMC
contractility (Kim et al. 2008). However, actomyosin-driven con-
tractility is not the only mechanosensitive role of the actin cyto-
skeleton. Of the 6 actin isoforms, ASMCs have been shown to
expressα-smooth muscle actin (αSMA),β-actin (also known as
β-non-muscle or β-cytoplasmic actin), γ-smooth muscle actin
(γSMA) and γ-cytoplasmic actin, in order of decreasing propor-
tion (Kim et al. 2008). Dedifferentiation of ASMCs from a con-
tractile phenotype reduces the expression of contractile actin iso-
forms αSMA and γSMA (Rensen et al. 2007). Actin exists
within two states, either a globular G-actin monomer or as fila-
mentous F-actin, an elongated, polar polymer (Gunst and Zhang
2008). Transition between the two states is regulated by ATP
binding and hydrolysis. ATP-bound G-actin typically binds at
the fast-growing barbed end of the actin filament, whilst ADP-
bound monomers generally dissociate from the opposing end,
causing the filament to treadmill (Wear et al. 2000). ASMCs
generate contractile force through the ATP-driven association
between actin filaments and myosin II. The mechanism through
which actomyosin complexes generate force has been extensive-
ly reviewed previously (Gunst and Zhang 2008; Tojkander et al.
2012; Yamin and Morgan 2012). In response to blood-derived
compression and stretch, ASMCs generate actomyosin-driven
contractility through the actions of two interlinked pathways:
the calcium-dependent and the Rho-ROCK pathway (Ahmed
and Warren 2018).
Upon mechanical loading, ASMCs reorganise their actin
cytoskeleton via a two-step response. Seconds after a force is
applied, actin filaments are stretched and align along the
direction of the force (Li et al. 2020). A few minutes later,
actin filaments become stabilised through the ATP-dependent
process of αSMA crosslinking. This enables myosin to inter-
act with the actin bundle, generating actomyosin-driven con-
tractile forces and providing a site for further actin filament
recruitment (Li et al. 2020). This demonstrates the dynamic
nature of the actin cytoskeleton and its responsiveness to ex-
ternal mechanical stimuli. As we age, the rigidity of the aortic
wall increases (Qiu et al. 2010). ASMCs sense increased ma-
trix stiffness and remodel their actin cytoskeleton. On a
collagen-I matrix, as stiffness increases, actin stress fibres
align, decreasing ASMC migration speed and distance
(Sanyour et al. 2019; Rickel et al. 2020). Actin stress fibre
alignment enhances actomyosin force generation, stiffening
ASMCs and further reduces arterial compliance (Sazonova
et al. 2015; Sanyour et al. 2019). However, this response is
not uniform across all ECM substrates. On rigid, fibronectin-
coated matrices actin stress fibre organisation decreases, and
ASMCmigration speed and persistence increase (Rickel et al.
2020). In addition, ASMCs undergo dedifferentiation and
adopt a proliferative phenotype (Sazonova et al. 2015). This
indicates that ECM composition and stiffness are both impor-
tant regulators of ASMC function.
Cycle-by-cycle variations in blood pressure exert mechan-
ical forces of variable amplitude onto ASMCs. These varia-
tions programme the contractile response of ASMCs through
fluctuation-driven mechanotransduction. Isolated aortic rings
placed under monotonous stretching (cycles of consistent
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Fig. 2 Changes in morphology allow mechanical programming of
ASMC phenotype. ASMCs are not terminally differentiated and
possess the ability to switch between contractile and proliferative
phenotypes. In vivo, quiescent ASMCs adopt a contractile, spindle-
shaped morphology and express smooth muscle contractile markers,
including α-smooth muscle actin (αSMA), smoothelin and smooth
muscle myosin II (SM-MII). ASMCs dedifferentiate into a proliferative
phenotype when grown in culture or upon mechanical or biochemical
stimulation. Proliferative ASMCs downregulate contractile marker
proteins and lose their spindle shape, adopting a morphology akin to a
fried egg. Cytoskeletal reorganisation within proliferative ASMCs
reduces actomyosin activity and promotes cell migration and proliferation
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in contrast to those undergoing variable stretching (variable
strain per cycle) which maintain a physiological level of con-
tractility (Bartolák-Suki et al. 2015). The application of stretch
triggers the actin cytoskeleton to reorganise, increasing its
organisation through the alignment of actin filaments. This
reorganisation enables the cell tomaintain intracellular tension
whilst under deformation (Bartolák-Suki et al. 2015). When
exposed to variable stretch, the amount of elastic potential
energy communicated to the cell is greater. This leads to an
enhanced alignment of the actin cytoskeleton, with cortical
actin in addition to contractile stress fibres undergoing
reorganisation (Bartolák-Suki et al. 2015). Actin cytoskeleton
reorganisation enhances the dispersal of tension and enables
the conduction of extracellular forces onto intercellular organ-
elle. Stretch-induced reorganisation of the actin cytoskeleton
in turn leads to reorganisation of the mitochondrial network.
Alignment of mitochondria enhances their efficiency, increas-
ing ATP production and decreasing reactive oxygen species
(ROS) by-production (Bartolák-Suki et al. 2015; Bartolák-
Suki and Suki 2020). These effects are again enhanced in
ASMCs exposed to variable as opposed to monotonous stress.
Increased availability of ATP enhances actin filament poly-
merisation and actomyosin force generation, establishing a
positive feedback loop which maintains the contractile ability
of ASMCs (Bartolák-Suki et al. 2015; Bartolák-Suki and Suki
2020). ASMCs are optimally tuned to physiological levels of
blood pressure variability. Pathologically high levels of vari-
ability experienced during hypertension disrupt the mitochon-
drial network and enhance ROS production (Bartolák-Suki
and Suki 2020). Elevated ROS impedes ASMC relaxation
and promotes enhanced expression of contractile proteins,
prolonging the contractile tone and stiffening the cell
(Bartolák-Suki and Suki 2020). However, the role of ROS in
regulating ASMC phenotype is not definitive, with ROS gen-
eration shown to both promote ASMC differentiation and de-
differentiation (Pi et al. 2013; Lee et al. 2016;Montezano et al.
2018; Tóth et al. 2020).
Mechanical remodelling of the actin
cytoskeleton regulates transcription
The actin cytoskeleton has been implicated in transcriptional
regulation via the myocardin-related transcription factors
(MRTF). MRTF-A is sequestered in the cytoplasm via inter-
actions with monomeric G-actin. Upon actin polymerisation,
MRTF-A dissociates and translocates to the nucleus where it
associates with the serum response factor (SRF) and promotes
SRF-dependant transcription (Mouilleron et al. 2011). SRF
activation by MRTF-A promotes the expression of smooth
muscle-specific contractile proteins (Wang et al. 2003;
Hinson et al. 2007). Cell morphology has also been implicated
in MRTF-A nuclear localisation (O’Connor and Gomez
2013). Importantly,MRTF-A nuclear translocation is alsome-
chanically regulated. Matrix rigidity and stretch induce actin
polymerisation and promote MRTF-A nuclear accumulation
(Dai et al. 2019; Montel et al. 2019). Activation of MRTF-A
has also been implicated in ASMC stiffening during hyperten-
sion, further confirming the importance of this pathway
(Lacolley et al. 2017).
Biomechanical stretching of ASMCs inhibits the Hippo-
kinase pathway, enabling the activation and nuclear
localisation of the transcriptional co-activators YAP/TAZ
(Wang et al. 2018). Nuclear accumulation of YAP/TAZ pro-
motes ASMC dedifferentiation, silencing the expression of
smooth muscle contractile markers and establishing a prolif-
erative and proinflammatory phenotype (Wang et al. 2018).
Active YAP reduces contractile marker expression by
disrupting the interaction between SRF and its co-activator
myocardin (Xie et al. 2012). During hypertension, elevated
angiotensin II signalling promotes the upregulation of YAP
expression within ASMCs. Inhibition of YAP or F-actin
depolymerisation alleviates hypertension-associated vascular
remodelling and ASMC dysfunction (Lin et al. 2018). Cell
shape and mechanical tension transmitted through the actin
cytoskeleton have been shown to regulate nuclear YAP/TAZ
accumulation in a variety of cell types (Dupont et al. 2011).
Given that the ASMC actin cytoskeleton undergoes
reorganisation in response to changes in the mechanical envi-
ronment, it stands to reason that these changes additionally
regulate ASMC activity and phenotype through the regulation
of YAP/TAZ.
It is clear that ASMC phenotype is regulated bymechanical
cues and the actin cytoskeleton. MRTF-A and YAP/TAZ are
critical components of this regulation (Fig. 3). YAP/TAZ pro-
motes ASMC dedifferentiation, whilst MRTF-A generally
promotes the ASMC contractile phenotype, although one
study has shown that following vascular injury MRTF-A up-
regulation contributes to enhanced ASMC proliferation
(Minami et al. 2012). However, both pathways are regulated
by similar mechanical cues. We lack an understanding of the
balance between these conflicting pathways. For example, is
there a mechanical threshold that differentiates between
MRTF-A and YAP/TAZ nuclear accumulation? Is it the same
for ASMCs from different vascular beds/embryonic origins?
Further research is needed to dissect the precise mechanisms
and thresholds regulating these pathways.
Microtubules—compression-resistant struts
In response to exogenous force, microtubules are proposed to
be compression-bearing, providing a resistive force against
deformation (Brangwynne et al. 2006). The cellular tensegrity
model proposes that interactions between actin filaments, mi-
crotubules and the ECM regulate cell stiffness, shape and
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deformability (Stamenović 2005). Microtubules and the ECM
balance pre-existing contractile stress generated by actin fila-
ments, providing shape and stability to the cell (Stamenović
2005). Microtubules are hollow, tube-like structures com-
prised of a helical array of polar protofilaments, formed from
the polymerisation of α/β-tubulin heterodimers. Existing in a
state of dynamic instability, microtubules constantly go
through phases of growth and shrinkage (Nogales 2001).
This intrinsic property enables microtubules to rapidly re-
spond to the changing requirements of the cell and regulate
processes including cell division, migration and intracellular
transport.
Interest in the ability of microtubules to regulate ASMC
force generation peaked around the turn of the century.
Microtubule depolymerisation increased ASMC contractility
and isometric force production (Leite and Webb 1998). This
finding held true regardless of the pharmacological method of
microtubule depolymerisation, or the mechanical or agonistic
approach used to induce contractility, although some vessel-
specific variations were reported (Sheridan et al. 1996; Platts
et al. 1999, 2002; Paul et al. 2000; Zhang et al. 2000). This
microtubule depolymerisation-dependent-enhanced force
generation could be blocked by pre-treating ASMCs with
the microtubule stabilising agent paclitaxel (brand name
Taxol) (Paul et al. 2000). However, paclitaxel treatment alone
has no effect on ASMC contractility (Zhang et al. 2000).
Actomyosin-driven ASMC contractility is regulated by
Ca2+-dependent and -independent pathways, both of which
are upregulated following microtubule destabilisation
(Sheridan et al. 1996). Increased intracellular Ca2+ levels are
detected in pulmonary and coronary artery rings following
microtubule depolymerisation (Paul et al. 2000). Meanwhile,
enhanced contractility within muscular arterioles can be
blocked by inhibiting the Rho-kinase pathway, which pro-
motes actomyosin activity through the phosphorylation of
the myosin light chain (Platts et al. 2002). Microtubules reg-
ulate Rho-kinase activity through the RhoA guanine nucleo-
tide exchange factor (GEF)-H1, which is usually microtubule
bound but is released upon microtubule depolymerisation
(Krendel et al. 2002). Release of GEF-H1 activates RhoA
and enhances actin stress fibre formation and actomyosin-
driven contractility (Krendel et al. 2002). Inhibition of Rho-
kinase blocked increased actin stress fibre and focal adhesion
formation in 3T3 fibroblasts following microtubule
depolymerisation (Liu et al. 1998). In addition to enhancing
force generation, microtubule disruption (depolymerisation or
stabilisation) also reduced the ability of vessels to vasodilate.
Impaired vasodilation occurred through both endothelial-
dependent (reduced nitric oxide production) and endothelial-
independent mechanisms (Leite and Webb 1998; Platts et al.
2002; Hemmer et al. 2009).
Despite microtubule depolymerisation resulting in en-
hanced force generation and impaired vasodilation, early stud-
ies found no increase in arterial stiffness, leading researchers
to believe that microtubules regulated ASMC contractility
solely through biochemical pathways (Paul et al. 2000).
However, the tensegrity model of microtubule compression
predicts that it is the resting equilibrium of load spread
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Fig. 3 Transcriptional regulation of ASMC phenotype. Mechanical
stimulation (e.g. matrix stiffness or biomechanical stretch) promotes
actin filament polymerisation, depleting the cytosolic pool of G-actin
and releasing myocardin-related transcription factor A (MRTF-A).
MRTF-A translocates to the nucleus where it interacts with serum
response factor (SRF) and promotes ASMC contractile differentiation
via the expression of contractile markers including α-smooth muscle
actin (αSMA), smoothelin and smooth muscle myosin II (SM-MII).
Conversely, mechanical stimulation also activates the transcriptional co-
activator YAP through inhibiting its phosphorylation and cytoplasmic
retention. Active YAP translocates to the nucleus and promotes ASMC
dedifferentiation into a proliferative phenotype, promoting the expression
of genes associated with extracellular matrix remodelling including
matrix metalloproteases (MMPs), collagenases and collagen-I.
Furthermore, active YAP disrupts the SRF-MRTF-A interaction,
preventing the expression of smooth muscle contractile markers
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between microtubules, actin filaments and the ECM that will
determine how a cell responds to microtubule disruption
(Stamenović 2005). In contractile ASMCs, microtubules align
roughly parallel to actin filaments in a fibrillar pattern (Zhang
et al. 2000). Under low strains, microtubule disruption has no
effect on ASMC stiffness, but as strain increases, microtu-
bules account for approximately 30% of ASMC tensile stiff-
ness (Nagayama and Matsumoto 2008). Therefore, microtu-
bules act to resist the intercellular tension generated through
actomyosin activity, which would otherwise compress intra-
cellular compartments. Microtubule depolymerisation lowers
the mechanical resistance of the cell and allows for enhanced
force generation following increased ASMC loading (Zhang
et al. 2000; Nagayama and Matsumoto 2008). Surprisingly,
microtubule stabilisation via paclitaxel treatment has no effect
on ASMC contractility, despite increasing microtubule densi-
ty by 30%. This suggests that the pre-existing microtubule
network within quiescent, contractile ASMCs is set up to pro-
vide the maximal compressive resistance available to the cell,
as a counterbalance to actomyosin activity (Zhang et al. 2000).
In addition to resisting compression, the microtubule net-
work has also been shown to regulate ASMC phenotype.
Microtubule destabilisation leads to increased CTGF (connec-
tive tissue growth factor) and PAI-1 (plasminogen activator
inhibitor-1) expression, a response that can be inhibited by
pre-treating ASMCs with a microtubule stabiliser
(Samarakoon et al. 2009). Both CTGF and PAI-1 are known
promoters of vascular fibrosis, with their expression leading to
increased MMP (matrix metalloproteinase) activity and en-
hanced collagen and fibronectin secretion (Lan et al. 2013).
Vascular fibrosis results in arterial stiffening. The effect of
arterial matrix stiffness on ASMC microtubule dynamics is
currently unknown; however, it has been shown in breast can-
cer lines that matrix stiffness can promote both microtubule
de/stabilisation (Heck et al. 2012; Torrino et al. 2021). ASMC
calcification, another CVD biomarker, has been associated
with decreased microtubule stability, with microtubule
stabilising agents able to impair the onset of phosphate-
induced ASMC calcification (Lee et al. 2014). Therapeutic
regulation of the microtubule cytoskeleton has proven effec-
tive in combatting angioplasty-induced restenosis, with clini-
cal trials identifying neointimal ASMC accumulation can be
prevented using the microtubule stabiliser paclitaxel (Sollott
et al. 1995; Stone et al. 2004; Gershlick et al. 2004).
Similar to actin filaments, the microtubule network can be
reorganised through the application of stress. Variable stress, as
opposed to monotonous stress, contributes to a greater organisa-
tion of the network (Bartolák-Suki et al. 2015). Microtubules
facilitate the intracellular transport of mitochondria; therefore, a
more aligned microtubule cytoskeleton enhances the organisa-
tion of themitochondrial network and increases the production of
ATP (Bartolák-Suki et al. 2015). Furthermore, under variable
stretch, VSMCs upregulate mitochondrial transport pathways,
with greater mitochondrial-microtubule association detected
compared to cells under monotonous or no stretch. As such,
destabilising the microtubule network decreases ATP produc-
tion, increases ROS release and impairs VSMC contractility
(Samarakoon et al. 2009; Bartolák-Suki et al. 2015). This finding
contrasts those reported earlier.
Intermediate filaments secure the mechanical
integrity of the cell
It has long been known that intermediate filaments provide
cells with an ability to withstand tension and provide mechan-
ical integrity. However, of the three main cytoskeletal compo-
nents, their role in mechanotransduction provides an under-
investigated area, with the majority of studies focusing on the
function of actin filaments (Sanghvi-Shah and Weber 2017).
Of the five cytoplasmic families of intermediate filaments,
ASMCs primarily express the Type III proteins vimentin
and desmin. Vimentin expression is ubiquitous, whilst desmin
is primarily expressed by ASMCs within small-muscular ar-
teries (Johansson et al. 1997; Wede et al. 2002). Additionally,
sporadic expression of cytokeratin in lumen proximal ASMCs
have been observed and is hypothesised to occur as cells de-
differentiate into a proliferative phenotype (Johansson et al.
1997). Unlike actin filaments and microtubules, intermediate
filament polymerisation is nonpolar and occurs in the absence
of enzymatic regulation. Vimentin monomers interact to form
parallel dimers, which in turn associate into antiparallel stag-
gered tetramers. These tetramers form the structural unit of
vimentin polymerisation, where 8 tetramers assemble head
to tail into a sheet that subsequently compacts into the rope-
like structure of vimentin intermediate filaments (VIFs)
(Chang and Goldman 2004).
The classical representation of VIFs is a dense, cage-like
network that encompasses the nucleus, with additional fila-
ments radiating out towards the cell periphery (Murray et al.
2014). In this representation, only a very small pool of soluble
vimentin exists within the cytoplasm, unlike those of G-actin
and tubulin dimers. However, these studies were performed
on glass or plastic. Cells grown on substrates mimicking phys-
iologically relevant stiffness yield far less vimentin within
insoluble cytoskeletal structures (Murray et al. 2014). On the
softest matrices, vimentin still forms a cage-like network
around the nucleus but fails to radiate outwards. As matrix
stiffness increases, VIFs expand further into the cytoplasmic
region. This indicates that, much like actin filaments, the po-
lymerisation of VIFs is dependent on the mechanical environ-
ment (Murray et al. 2014). Of the three cytoskeletal compo-
nents, intermediate filaments are the most resistant to strain.
Where actin filaments yield under 20% and microtubules 60%
strain, VIFs can withstand more than 80% strain (Janmey et al.
1991). Vimentin displays unusual viscoelastic properties. It is
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less rigid under low strain but hardens as strain increases,
thereby preventing VIFs from fracturing (Janmey et al.
1991). The ability of VIFs to maintain their integrity under
strains where actin filaments and microtubules yield provides
a mechanism for cells to respond to deformation. Stabilised
VIFs transmit localised stress/strain throughout the cell, dissi-
pating force and maintaining cell integrity (Janmey et al.
1991; Hu et al. 2019).
The role of vimentin in ASMC mechanotransduction
has been investigated using the global vimentin knockout
(KO) mouse (Langlois et al. 2017). A caveat to this ap-
proach is the dual expression of vimentin within endothe-
lial cells and ASMCs that convolutes the ability to trace
the biological significance of vimentin to a particular cell
type. Loss of vimentin altered expression of ECM com-
ponents within the subendothelial basement membrane,
with increased expression of fibronectin, laminin and col-
lagen IV (Langlois et al. 2017). Whilst these ECM com-
ponents are not typically associated with increased vascu-
lar stiffness, their overexpression creates a thicker, denser
ECM environment that displays an altered topography. In
response, ASMCs lose their spindle-shaped lamellar orga-
nisation and decrease expression of contractile markers
(Langlois et al. 2017; van Engeland et al. 2019).
Phenylephrine-induced contractility increased and
endothelium-dependent vasodilation decreased, leading
to an overall increase in arterial stiffness (Langlois et al.
2017).
Global vimentin KO decreases the ability of resistance ar-
teries to vasodilate in response to flow-derived shear stress
(Henrion et al. 1997). Shear stress primarily affects the endo-
thelium, perturbing ASMC relaxation by altering endothelial
nitric oxide production (Quillon et al. 2015). However, the
stress applied to the endothelium also transduces strain onto
ASMCs. In response to strain, ASMCs undergo enhancedVIF
polymerisation, increasing both their ability to withstand ten-
sion and their interaction with Jagged-1, in turn enhancing the
transactivation of Notch-3 (van Engeland et al. 2019). ASMCs
lacking Notch-3 promote arterial stiffening through the com-
bined effects of enhanced pressure-induced myogenic tone
and reduced flow-driven vasodilation. Furthermore, the ab-
sence of Notch-3 resulted in abnormal cytoskeletal rearrange-
ments that correlated with altered ASMC morphology and
organisation, including ASMCdetachment from the overlying
endothelium (Ruchoux et al. 2003; Dubroca et al. 2005).
Desmin intermediate filaments are another cytoskeletal com-
ponent whose role in mechanotransduction warrants further
investigation. Loss of desmin reduces the circumferential ten-
sion and sustains the contractile phase within microarterial
resistance vessels (Wede et al. 2002). Furthermore, ASMC
desmin expression is regulated by matrix stiffness and topog-
raphy, with enhanced stiffness or reduced patterning decreas-
ing desmin expression (Chaterji et al. 2014). Intermediate
filaments are clearly important for ASMC response to me-
chanical cues. More research is needed to define howmechan-
ical cues in health and disease regulate this filamentous
system.
Conclusions and perspectives
VSMC differentiation and function are highly complex and
intricate processes that incorporate both mechanical and bio-
chemical components. At the heart of these processes are the
cytoskeletal networks that are critical determinants of ASMC
fate. Where traditional, well-defined roles for cytoskeletal
components existed, it is now becoming clear that the cyto-
skeleton adapts as necessary following homeostatic force dis-
ruption. Emerging evidence suggests that both external and
internal cues drive the mechanical programming of ASMC
phenotype and function. This implies that the mechanical en-
vironment is a major determinant of ASMC fate. However,
key unanswered questions remain, including: (1) the interplay
between the different cytoskeletal systems in ASMC function;
(2) identification of the differential mechanisms and mechan-
ical thresholds that regulate these responses; and (3) do
ASMCs from different arteries display similar response to
mechanical loading? ASMC morphology and cytoskeletal or-
ganisation are key contributors to ASMC phenotype.
Therefore, the development and use of tools to better model
in vivo organisation and mechanical environments are essen-
tial and likely to yield novel mechanistic information that
better describes ASMC function.
Whilst it is acknowledged that the mechanical forces acting
on the vascular system are intertwined, when studying their
effects, we typically focus on a stimulus in isolation. This has
enabled the technologies required to model mechanical cues
such as matrix stiffness, biomechanical stretch, flow and hy-
drostatic pressure to be developed. However, we lack a key
understanding of the bigger picture. For example, how do
ASMCs respond to the summation of these forces? In vivo,
ASMCs exist in a 3-dimentional environment, yet due to tech-
nological limitations the majority of studies described in this
review were performed on 2-dimentional substrates. The de-
velopment of 3-dimentional scaffolds of tuneable stiffness that
can be subjected to compressive forces will drive the next
phase of our understanding of ASMC plasticity and function.
Furthermore, ASMCs are not the only cell type within the
aortic wall. Modifying existing technologies to enable the ef-
fects of mechanical cues on ASMC-endothelial cell co-
cultures is essential. Combining such advancements in model-
ling with techniques such as bulk or single-cell RNA sequenc-
ing would enable a more thorough understanding of how
ASMCs respond to mechanical stimuli. Additionally, it would
help explain how mechanical insults modulate the transcrip-
tional regulation of ASMC differentiation. These techniques
Biophys Rev
have recently shown that genes associated with actin filament
reorganisation become upregulated in ASMCs during ageing
or disease but involvement of the mechanical landscape re-
mains unknown (Dobnikar et al. 2018; Gao et al. 2020;
Conklin et al. 2021).
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